{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urinary-tract-infection-lower-women/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"182ae581-d75a-507d-8146-e0d7d26dcad8","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 1891dfa9-3f89-47a3-ab2c-a9d700f3ee4f --><h2>How should I assess a person with suspected UTI?</h2><!-- end field 1891dfa9-3f89-47a3-ab2c-a9d700f3ee4f -->","summary":"","htmlStringContent":"<!-- begin item 75a03511-6978-43f8-b26c-a9d700f3edf8 --><!-- begin field 0fff89bc-137f-484f-8e09-a9d700f3ee4f --><p><strong>Take a history asking about:</strong></p><ul><li><strong>Onset and evolution of <a class=\"topic-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/diagnosis/when-to-suspect-uti/\">clinical features</a></strong> (such as dysuria, nocturia and changes in urine appearance or odour).<ul><li>In older women or those with cognitive impairment UTI may present atypically with delirium or debility — exclude other causes of delirium (such as pain, other infection, constipation, poor hydration, and medication).</li><li>For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/delirium/\">Delirium</a>.</li></ul></li><li><strong>Other symptoms</strong> such as vaginal or urethral discharge, irritation or skin rash which may indicate a cause other than UTI.</li><li><strong>Red flags</strong> such as haematuria, loin pain, rigors, nausea, vomiting, and altered mental state — consider the possibility of serious illness such as sepsis.</li><li><strong>Family history</strong> of urinary tract disease such as polycystic kidney disease.</li><li><strong>Possibly of pregnancy </strong>in women of childbearing age — carry out a pregnancy test if unsure.</li><li><strong>Past medical history including </strong><a class=\"topic-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/background-information/causes/\">risk factors for recurrent UT</a> such as neurological conditions, diabetes mellitus, immunosuppression, urolithiasis, and bladder catheterisation.</li><li><strong>Medication</strong> including recent antibiotics.</li></ul><p><strong>Examine the person:</strong></p><ul><li>Check vital signs (such as temperature, blood pressure, heart rate and respiratory rate) looking for signs of systemic illness or sepsis.</li><li>Palpate for flank or suprapubic tenderness and pelvic or abdominal masses.<ul><li>Consider <a class=\"topic-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/diagnosis/differential-diagnosis/\">other diagnoses</a> (for example pyelonephritis, obstruction or malignancy) if the person has significant abdominal pain, flank tenderness or a pelvic or abdominal mass.</li></ul></li><li>Check for blockage if there is a urinary catheter in situ.</li><li>Assess other systems depending on suspected cause, for example, genital examination if vulvovaginal atrophy or herpes simplex is a possibility.</li></ul><p><strong>Consider the need for investigations:</strong></p><ul><li><strong>If the woman is under 65 years of age, and does not have risk factors for complicated UTI, urine dipstick can be used as an aid to diagnosis — </strong>dipstick is unreliable in women aged older than 65 years and those who are catheterised<strong>.</strong><ul><li>If dipstick is positive for nitrite <em>or</em> leukocyte <em>and</em> red blood cells (RBC) UTI is likely.<ul><li>A urine sample (morning sample most reliable) for culture and sensitivities should be sent if previous antibiotic treatment has failed or there is a possibility of antibiotic resistance.</li><li>Sample containers with boric acid preservative should be filled to the marked line.</li></ul></li><li>If urine dipstick is negative for nitrite <em>and</em> positive for leukocyte, UTI is equally likely to other diagnosis.<ul><li>Send urine for culture to confirm diagnosis.</li></ul></li><li>If urine dipstick is negative for all nitrite, leukocyte and RBC, UTI is less likely.<ul><li>No need to send sample for urine culture — consider other diagnoses.</li></ul></li></ul></li><li><strong>A sample should be sent for urine culture in <em>all </em>women with suspected lower UTI who:</strong><ul><li>Are pregnant.</li><li>Are older than 65 years.</li><li>Have symptoms that are persistent or do not resolve with antibiotic treatment.</li><li>Have recurrent UTI (2 episodes in 6 months or 3 in 12 months).</li><li>Have a urinary catheter in situ or have recently been catheterised.<ul><li>If the catheter has been changed the sample should be collected from the newly placed catheter — using aseptic technique drain a few mL of residual urine from the tubing then collect a fresh sample from catheter sampling port.</li><li>Ensure the microbiology request form states that this is a suspected catheter-associated infection and details of any antibiotic prescribed.</li></ul></li><li>Have risk factors for resistance or complicated UTI such as abnormalities of genitourinary tract, renal impairment, residence in a long term care facility, hospitalisation for more than 7 days in the last 6 months, recent travel to a country with increased resistance or previous resistant UTI.</li><li>Have atypical symptoms.</li><li>Have visible or non-visible (on urine dipstick) haematuria.</li></ul></li><li><strong>Other investigations such as cystoscopy or imaging in secondary care</strong> may be appropriate if an underlying cause is suspected.</li></ul><!-- end field 0fff89bc-137f-484f-8e09-a9d700f3ee4f --><!-- end item 75a03511-6978-43f8-b26c-a9d700f3edf8 -->","topic":{"id":"4205a2dd-1d74-53f2-90f4-5239307d2883","topicId":"7e36f7cd-e707-44db-a683-f4197a84b187","topicName":"Urinary tract infection (lower) - women","slug":"urinary-tract-infection-lower-women","lastRevised":"Last revised in October 2020","chapters":[{"id":"96f75303-a8ae-50a0-9d5c-e5a9b96e67f1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"cafb451d-db29-558a-a6cc-20d82dde3df9","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"14a65465-7aa4-5024-bb53-b3b2099b526a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"7b90ea0f-0f86-5457-965d-930656bd2f02","slug":"changes","fullItemName":"Changes"},{"id":"4f3fd7bc-437b-509c-9a2d-5318de2b1e8b","slug":"update","fullItemName":"Update"}]},{"id":"850e1193-41eb-50b7-b401-ac0396c6e585","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"18c79474-b4ac-50cd-801a-3738d79a1159","slug":"goals","fullItemName":"Goals"},{"id":"24f4bdf7-0aa4-5f6b-a117-2c3a7da00984","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6b590746-634f-5a0c-b995-5f98bd9c6f0d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4c2be4f2-9e65-53d3-8ff6-7534932e7dc6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"835cf60d-f7b4-57b8-97ee-607930381034","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a526f295-371c-52d5-bd46-93333947aade","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"28adde3c-64d3-5e21-8797-08c56ab570c5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"4a732f85-1f37-5288-a872-611c3528c53e","slug":"definition","fullItemName":"Definition"},{"id":"8e922399-2c9d-5777-9660-944733f631f5","slug":"causes","fullItemName":"Causes"},{"id":"8fa46cfc-d97b-5218-847f-9553a7ce2854","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c9ad7aa8-f54d-55a8-b6f1-804d616de2b4","slug":"prognosis","fullItemName":"Prognosis"},{"id":"a176b8d4-1d8f-5f62-935e-4f6fc4696153","slug":"complications","fullItemName":"Complications"}]},{"id":"03286f6f-e3d8-5889-8453-1db9ffb07914","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ec9700ef-7ba2-524e-868a-3dc60b345625","slug":"when-to-suspect-uti","fullItemName":"When to suspect UTI"},{"id":"182ae581-d75a-507d-8146-e0d7d26dcad8","slug":"assessment","fullItemName":"Assessment"},{"id":"5dfac6cd-ec1e-5d54-98a4-a65cf57457d9","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"6d45128d-30db-5879-917a-4a6e682fa7e9","fullItemName":"Management","slug":"management","subChapters":[{"id":"a72789b5-d51e-5516-8ab1-942aae1e0fe8","slug":"uti-no-visible-haematuria-not-pregnant-or-catheterized","fullItemName":"Scenario: UTI  (no visible haematuria, not pregnant or catheterized)"},{"id":"91dbd4da-8761-5e78-9eb2-a773cc7d2764","slug":"uti-with-visible-or-non-visible-haematuria","fullItemName":"Scenario: UTI  with visible or non-visible haematuria"},{"id":"3e093a06-3197-58a5-8c61-94586835adba","slug":"recurrent-uti-no-visible-haematuria-not-pregnant-or-catheterized","fullItemName":"Scenario: Recurrent UTI  (no visible haematuria, not pregnant or catheterized)"},{"id":"09df152e-ea9c-51c1-917c-5c4c01ab2fc8","slug":"uti-in-pregnancy-no-visible-haematuria","fullItemName":"Scenario: UTI in pregnancy  no visible haematuria"},{"id":"6d0e09de-6e28-53df-b01b-55fc899c0dd7","slug":"asymptomatic-bacteriuria-in-pregnancy","fullItemName":"Scenario: Asymptomatic bacteriuria in pregnancy"},{"id":"07efc80a-4963-5037-a8f2-c5b63d298205","slug":"uti-with-catheter-no-haematuria","fullItemName":"Scenario: UTI with catheter  no haematuria"}]},{"id":"7a32c4da-f7b1-5664-92e2-e1fdeca6361a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b42d0bbc-d0ac-52c7-83bf-5fc7a76a38dc","slug":"trimethoprim","fullItemName":"Trimethoprim"},{"id":"76a10025-1806-5d3b-96b0-72401241a768","slug":"nitrofurantoin","fullItemName":"Nitrofurantoin"},{"id":"625120b5-8124-549f-b13c-8b37bea158ff","slug":"pivmecillinam","fullItemName":"Pivmecillinam"},{"id":"bae5a7ea-ae42-56ba-82cc-74cbc655059f","slug":"fosfomycin","fullItemName":"Fosfomycin"},{"id":"e8dc8860-ec55-59c6-96c0-805260cb7172","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"e5121975-a684-5651-bf41-c324e815c0f5","slug":"cefalexin","fullItemName":"Cefalexin"}]},{"id":"332fba52-4a32-56f0-b721-29ac73f73e6d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8f34f8fc-4bd2-54e3-87f0-a4a1394f3891","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9b392302-d709-5520-a890-25e10021e12b","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0d4bbe1a-f3f6-523c-85c0-1fae02dd5b27","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"84ca6e0f-7674-5f70-b099-406d5c783d89","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4ed139aa-715a-523d-8c0a-8f4e167d29df","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"067e363b-53be-5584-a0e9-2bf38e519877","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"045ecabb-df97-5df3-b561-ecddea4b7b17","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"03286f6f-e3d8-5889-8453-1db9ffb07914","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"cd3c528a-0f03-52b4-90f3-70a997083fb1","slug":"basis-for-recommendation-2fa","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 52c1edd3-9740-4012-af3e-a9d700f4306e --><h3>Basis for recommendation</h3><!-- end field 52c1edd3-9740-4012-af3e-a9d700f4306e -->","summary":null,"htmlStringContent":"<!-- begin item 2fa3d222-f1d4-4995-b132-a9d700f4303c --><!-- begin field 23874bc9-192a-4ce6-b3a0-a9d700f4306e --><p>The recommendations on the assessment of women with suspected UTI are based on the clinical guidelines <em>Guidance on management of recurrent urinary tract infection in non-pregnant women</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Scottish Medicines Consortium and Scottish Antimicrobial Prescribing Group, 2016</a>], <em>Committee Opinion No. 703 Summary: Asymptomatic Microscopic Hematuria in Women</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">ACOG, 2017a</a>], <em>Recurrent Urinary Tract Infection</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Epp, 2017</a>] <em>Diagnosis of urinary tract infections (UTIs). Quick reference guide for primary care: for consultation and local adaptation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>], <em>Urological infections</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>], <em>Catheter associated urinary tract infections: antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>] and <em>UK standards for microbiological investigations. Investigation of urine</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2018a</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Hole, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Mody, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Michels, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Johnston, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">BMJ Best Practice, 2018c</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Gbinigie, 2018</a>].</p><h4>Clinical features consistent with UTI</h4><ul><li>Guidance from Public Health England (PHE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] and the European Association of Urology (EAU) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>] agrees that in women without risk factors for complicated UTI the presence of lower urinary tract symptoms in the absence of vaginal discharge or irritation is suggestive of a diagnosis of lower UTI.</li></ul><h4>Red flags</h4><ul><li>Guidance from the National Institute for Health and Care Excellence (NICE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>] and Public Health England [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] highlight the importance of appropriate clinical assessment (including checking vital signs) to identify clinical features of systemic infection, sepsis or pyelonephritis.</li><li>Haematuria (visible and non-visible) should be considered a red flag to ensure that serious underlying conditions such as urological malignancies are not missed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2017b</a>].</li></ul><h4>Atypical presentation in older women or those with cognitive impairment</h4><ul><li>Guidance from the Scottish Intercollegiate Guidelines Network [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">SIGN, 2012</a>] and PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Ninan, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Gbinigie, 2018</a>] recognises that women over 65 years may present atypically with non-specific signs of infection such as delirium, reduction in ability to carry out activities of daily living and loss of diabetic control – a full clinical assessment is required to exclude other causes before treating for UTI.</li></ul><h4>Pregnancy</h4><ul><li>Pregnancy should be excluded in all women of child-bearing age as untreated UTI in pregnancy is associated with premature labour and low-birthweight [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2017a</a>].</li></ul><h4>Symptoms that may indicate another cause of dysuria</h4><ul><li>Urinary symptoms can be due to urethral inflammation (for example due to sexually transmitted infections, inflammation post sexual intercourse or contact with irritants) or symptoms of menopause, atrophic vaginitis or vaginal atrophy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>].<ul><li>75-80% of women with vaginal discharge will not have a UTI — other genitourinary causes of urinary symptoms (including sexually transmitted infections) should be excluded [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>].</li></ul></li><li>Expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Michels, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">BMJ Best Practice, 2018c</a>] recommends assessment of other systems depending on the specific clinical presentation for example reactive arthritis or Bechet’s syndrome may present with urethritis in association with arthralgia, conjunctivitis, and gastrointestinal symptoms.</li></ul><h4>Investigations</h4><ul><li>The recommendation on investigations for suspected lower UTI in women are based on clinical guidelines from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2018a</a>], EAU [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>] and NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>].</li><li>Urine dipstick should not be used to diagnose UTI in women over the age of 65 years, in those with a urinary catheter, for recurrent UTI or where there is a chance of bacterial resistance – a urine culture should be sent [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>].<ul><li>Dipsticks are more unreliable with increasing age — up to half of older adults and most with a urinary catheter have asymptomatic bacteriuria which causes a positive urine dipstick but is not harmful and does not require treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>].</li><li>A urine sample for culture should be sent (f possible before starting antibiotics) in women who are catheterized as there is an increased likelihood of antimicrobial resistance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>].</li></ul></li><li>Dipstick can be used to aid diagnosis of UTI in women under the age of 65 years without risk factors for complicated UTI [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>].<ul><li>Guidance from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] states that if dipstick is positive for nitrite or leukocyte and red blood cells (RBC) UTI is likely; if urine dipstick is negative for nitrite and positive for leukocyte, UTI is equally likely to other diagnoses; and if urine dipstick is negative for all nitrite, leukocyte and RBC UTI less likely than other diagnoses.</li><li>Guidance from the EAU recommends dipstick testing if the diagnosis of UTI is unclear as this can increase the likelihood of an uncomplicated cystitis diagnosis if leukocytes and nitrite are positive, only nitrite or nitrite and blood are positive or leukocytes and blood are positive [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>].</li><li>Use of symptoms and dipsticks to diagnose UTI is not completely reliable — severity of symptoms must be considered in each specific case and appropriate safety-netting put in place [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>].</li><li>PHE recommends that women with three key diagnostic signs/symptoms (dysuria, new nocturia, cloudy urine) can be considered for an immediate antibiotic, or a backup antibiotic without dipstick testing, and that in women with one or no signs/symptoms, dipstick testing is appropriate [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2018b</a>].<ul><li>However, it states that no individual or combination of symptoms and dipstick testing are completely reliable in diagnosing UTI, so the severity of symptoms and safety-netting are important in all women with suspected UTI.</li></ul></li><li>SIGN recommends that UTI should be diagnosed in women in the presence of two or more urinary symptoms (dysuria, frequency,urgency, visible haematuria or nocturia) and a positive dipstick test result for nitrite [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">SIGN, 2020</a>].</li></ul></li><li>Urine samples in universal containers should be cultured within 4 hours of collection, refrigerated, or sent in a container with boric acid preservative [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>].<ul><li>Boric acid can affect urine dipstick tests and cause false negative culture if urine is not filled to correct mark on specimen bottle.</li></ul></li><li>Recommendations on when to send a urine culture are based on clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Scottish Medicines Consortium and Scottish Antimicrobial Prescribing Group, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Epp, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">All Wales Medicines Strategy Group, 2018</a>].<ul><li>A follow-up urine sample is not required unless pregnant, or advised by the laboratory [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>].</li></ul></li></ul><h4>Complicating or atypical features</h4><ul><li>The presence of complicating or atypical features (including persistent haematuria or recurrent UTI) should prompt consideration of referral to secondary care for further assessment to exclude serious underlying conditions (such as malignancy) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Hole, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Michels, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Scottish Medicines Consortium and Scottish Antimicrobial Prescribing Group, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2017b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Quinlan, 2017</a>].</li></ul><!-- end field 23874bc9-192a-4ce6-b3a0-a9d700f4306e --><!-- end item 2fa3d222-f1d4-4995-b132-a9d700f4303c -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}